Indications
Maintenance treatment of asthma in adults whose disease is not adequately controlled.
Composition
- Active substance
- glycopyrronium bromide, Indacaterol (acetate), mometasone furoate
- International name (INN)
- indacaterol;glycopyrronium;mometasone furoate
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zimbus Breezhaler
- Active substance
- glycopyrronium bromide, Indacaterol (acetate), mometasone furoate
- ATC code
- R03AL
- Group
- Respiratory system
- Therapeutic area
- Asthma
- Marketing authorisation holder
- Novartis Europharm Limited